Die FDA bietet keinen selbst aktualisierenden News-Dienst an, Informationen über aktuelle FDA-Zulassungen können auf der FDA-Homepage eingesehen werden.

Der kommerzielle Anbieter drugs.com publiziert einen Nachrichtendienst mit Informationen zu allen Neuzulassungen der FDA.

• FDA Approves Utebzi (tebipenem pivoxil) for Adults with Complicated Urinary Tract Infections
  17.06.2026
  GSK plc (LSE/NYSE: GSK) and Spero Therapeutics (Nasdaq: SPRO) today announced that the US Food and Drug Administration (FDA) has approved Utebzi, an oral antibiotic […]
• Sanofi’s Tzield Approved in the US as the First Disease-Modifying Therapy for Patients Recently Diagnosed with Stage 3 Type 1 Diabetes
  13.06.2026
  Paris, June 13, 2026. The US Food and Drug Administration (FDA) has granted accelerated approval to Tzield (teplizumab-mzwv) to delay the decline in endogenous (own) […]
• FDA Approves Lilly's Ebglyss (lebrikizumab-lbkz) for One Maintenance Dose Every Eight Weeks in Patients with Moderate-to-Severe Atopic Dermatitis
  09.06.2026
  INDIANAPOLIS, June 9, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved a regimen […]
• U.S. FDA Approves Pfizer’s Hympavzi for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
  09.06.2026
  NEW YORK–(BUSINESS WIRE) June 08, 2026 — Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded […]
• FDA Approves Xocova (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
  02.06.2026
  OSAKA, Japan, June 1, 2026 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced that the […]